News
Sanofi gets double blow for MS drug tolebrutinib
Shares in Sanofi have slid on a double dose of bad news for its oral BTK inhibitor tolebrutinib, in development as a therapy for multiple sclerosis.
News
GSK closes on approval of asthma hope depemokimab
GSK is poised for the first major approval of depemokimab, a long-acting drug for severe asthma that can be dosed just twice a year.
Market Access
UK pharma policy at a turning point: NICE threshold reform, ...
The ICER threshold increase is expected to allow an additional three to five medicines or indications each year to be recommended for NHS use.
Market Access
The UK-US drug pricing deal: A welcome step, but not the fin...
The UK-US deal eases medicines pricing uncertainty, lifts NICE threshold, and boosts confidence, but UK pharma still needs pricing reform
News
CHMP decision levels the playing field for GSK's RSV jab
GSK's RSV vaccine is poised for EU approval in all adults aged 18 and over, bringing it into line with rival shots from Pfizer and Moderna.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
